Search

Author/Creator Cha, Hongui

1. Artificial Intelligence–Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non–Small-Cell Lung Cancer. Issue 17 (10th June 2022)

Authors:
Park, Sehhoon; Ock, Chan-Young; Kim, Hyojin; Pereira, Sergio; Park, Seonwook; Ma, Minuk; Choi, Sangjoon; Kim, Seokhwi; Shin, Seunghwan; Aum, Brian Jaehong; Paeng, Kyunghyun; Yoo, Donggeun; Cha, Hongui; Park, Sunyoung; Suh, Koung Jin; Jung, Hyun Ae; Kim, Se Hyun; Kim, Yu Jung; Sun, Jong-Mu; Chung,...
Journal:
Journal of clinical oncology
Issue:
Volume 40:Issue 17(2022)
Page Start:
1916
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Clinical advantage of targeted sequencing for unbiased tumor mutational burden estimation in samples with low tumor purity. Issue 2 (19th October 2020)

Authors:
Hong, Tae Hee; Cha, Hongui; Shim, Joon Ho; Lee, Boram; Chung, Jongsuk; Lee, Chung; Kim, Nayoung K D; Choi, Yoon-La; Hwang, Soohyun; Lee, Yoomi; Park, Sehhoon; Jung, Hyun Ae; Kim, Ji-Yeon; Park, Yeon Hee; Sun, Jong-Mu; Ahn, Jin Seok; Ahn, Myung-Ju; Park, Keunchil; Lee, Se-Hoon; Park, Woong-Yang
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Clinical advantage of targeted sequencing for unbiased tumor mutational burden estimation in samples with low tumor purity. Issue 2 (19th October 2020)

Authors:
Hong, Tae Hee; Cha, Hongui; Shim, Joon Ho; Lee, Boram; Chung, Jongsuk; Lee, Chung; Kim, Nayoung K D; Choi, Yoon-La; Hwang, Soohyun; Lee, Yoomi; Park, Sehhoon; Jung, Hyun Ae; Kim, Ji-Yeon; Park, Yeon Hee; Sun, Jong-Mu; Ahn, Jin Seok; Ahn, Myung-Ju; Park, Keunchil; Lee, Se-Hoon; Park, Woong-Yang
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Clinical advantage of targeted sequencing for unbiased tumor mutational burden estimation in samples with low tumor purity. Issue 2 (19th October 2020)

Authors:
Hong, Tae Hee; Cha, Hongui; Shim, Joon Ho; Lee, Boram; Chung, Jongsuk; Lee, Chung; Kim, Nayoung K D; Choi, Yoon-La; Hwang, Soohyun; Lee, Yoomi; Park, Sehhoon; Jung, Hyun Ae; Kim, Ji-Yeon; Park, Yeon Hee; Sun, Jong-Mu; Ahn, Jin Seok; Ahn, Myung-Ju; Park, Keunchil; Lee, Se-Hoon; Park, Woong-Yang
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Clinical advantage of targeted sequencing for unbiased tumor mutational burden estimation in samples with low tumor purity. Issue 2 (19th October 2020)

Authors:
Hong, Tae Hee; Cha, Hongui; Shim, Joon Ho; Lee, Boram; Chung, Jongsuk; Lee, Chung; Kim, Nayoung K D; Choi, Yoon-La; Hwang, Soohyun; Lee, Yoomi; Park, Sehhoon; Jung, Hyun Ae; Kim, Ji-Yeon; Park, Yeon Hee; Sun, Jong-Mu; Ahn, Jin Seok; Ahn, Myung-Ju; Park, Keunchil; Lee, Se-Hoon; Park, Woong-Yang
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Clinical advantage of targeted sequencing for unbiased tumor mutational burden estimation in samples with low tumor purity. Issue 2 (19th October 2020)

Authors:
Hong, Tae Hee; Cha, Hongui; Shim, Joon Ho; Lee, Boram; Chung, Jongsuk; Lee, Chung; Kim, Nayoung K D; Choi, Yoon-La; Hwang, Soohyun; Lee, Yoomi; Park, Sehhoon; Jung, Hyun Ae; Kim, Ji-Yeon; Park, Yeon Hee; Sun, Jong-Mu; Ahn, Jin Seok; Ahn, Myung-Ju; Park, Keunchil; Lee, Se-Hoon; Park, Woong-Yang
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Transcriptional upregulation of CXCL13 is correlated with a favorable response to immune checkpoint inhibitors in lung adenocarcinoma. (1st December 2022)

Authors:
Park, Sehhoon; Cha, Hongui; Kim, Hong Sook; Lee, Boram; Kim, Soyeon; Kim, Tae Min; Jung, Hyu Ae; Sun, Jong‐Mu; Ahn, Jin Seok; Ahn, Myung‐Ju; Park, Keunchil; Park, Woong‐Yang; Lee, Se‐Hoon
Journal:
Cancer medicine
Issue:
Volume 12:Number 6(2023)
Page Start:
7639
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗